New Dual-Target Drug Amycretin Achieves 24% Weight Loss in Clinical Trials
Novel obesity drug targeting two pathways simultaneously shows unprecedented weight loss results in recent clinical studies.
158 articles in this topic
Novel obesity drug targeting two pathways simultaneously shows unprecedented weight loss results in recent clinical studies.
Major study of 255,000+ people shows optimal cardiovascular health dramatically reduces disease progression and mortality risk.
Scientists identified 31 blood molecules that predict diabetes mortality risk, offering early warning signs for prevention.
New research reveals how SREBP2 protein triggers liver fibrosis through metabolic changes, offering hope for treating liver disease.
Large study reveals specific blood proteins can identify who will die from heart disease a decade before death occurs.
SGLT2 inhibitor canagliflozin prevents cardiovascular harm from low-sodium diets in diabetic kidney disease patients.
Major diabetes organizations call for individualized tech approaches to overcome access barriers and reduce health disparities.
Major study shows CGM users had dramatically lower rates of complications and death compared to traditional monitoring methods.
New research reveals how regular physical activity directly prevents and slows progression of major age-related diseases.
New research reveals how gut bacteria, toxic fats, and immune responses create parallel inflammatory attacks on the liver.
Scientists identify how different immune cells use specific nutrient transporters, revealing new targets for autoimmune diseases.
New research reveals mitochondria use lactate to prevent oxidative damage rather than generate energy, challenging conventional wisdom.